CI

At a glance

ClinicalIndex Comparison Record
N/AActive· 60 enrolled
Drug / intervention
Moderate-Intensity Aerobic Exercise +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03975491
NCT03975491N/AActive
CompareCT.gov

The Exercise And Colorectal Cancer Treatment (EXACT) Trial

Pennington Biomedical Research Center·interventional·Posted Jun 5, 2019·Updated Sep 22, 2025

In Brief

A clinical study evaluating Moderate-Intensity Aerobic Exercise and Wait-List Control for Colon Cancer and Rectal Cancer. Active but no longer recruiting, targeting 60 participants across 1 site.

Detailed Summary

This study will examine the biologic processes through which exercise may prevent disease recurrence in patients who have completed treatment for colorectal cancer.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsColon Cancer, Rectal Cancer
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)

Timeline

N/AActiveOverdue
2020202120222023202420252026
First PostedJun 5, 2019
Enrollment StartAug 1, 2019
Primary CompletionMay 1, 2023
Study CompletionJan 1, 2026
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 7.1 years ago

Interventions

Moderate-Intensity Aerobic Exercisebehavioral

The exercise intervention will consist of moderate-intensity (50-70% age-predicted maximum heart rate) treadmill walking. All exercise sessions will begin with a five-minute warm up of slow walking, 30-60 minutes of moderate-intensity walking, and a five-minute cool down of slow walking.

Wait-List Controlbehavioral

Participants randomized into the wait-list control group are asked to maintain their pre-study levels of physical activity and follow the recommendations provided by their physician.